Company profile: FEI
1.1 - Company Overview
Company description
- Provider of high-performance microscopy workflow solutions, designing, manufacturing, and supporting electron microscopes and FIB-SEM instruments for nanoscale imaging and sample preparation; Ion Torrent next-generation sequencing systems; monoclonal antibody development and support services; Thermo Scientific laboratory equipment; and custom and bulk lab chemicals.
Products and services
- Electron Microscopy: High-performance instruments that image micrometer and nanometer structures, resolve single atoms, and analyze material composition, structure, and performance for breakthrough discovery workflows
- FIB-SEM Instruments: Integrated systems combining focused ion beam sample modification with high-resolution SEM imaging to enable TEM sample preparation, 3D characterization, and nanoprototyping for advanced materials research
- Ion Torrent NGS Instruments: Semiconductor-based platforms delivering fast, scalable sequencing on chip, supporting applications in inherited diseases, oncology, infectious diseases, and other genomic investigations
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to FEI
MicroLiquid
HQ: Spain
Website
- Description: Provider of contract development and manufacturing of polymer microfluidic disposable devices and life science microfluidic products for worldwide customers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MicroLiquid company profile →
BIA Separations
HQ: Slovenia
Website
- Description: Provider of proprietary monolithic chromatography columns based on CIM Convective Interaction Media technology for production, purification, and analysis of large biomolecules, including viruses, plasmid DNA, exosomes, antibodies, bacteriophages, and large proteins. Offers CIMmultus preparative and CIMac analytical columns, PATfix analytical standards, and Cornerstone services and process development support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BIA Separations company profile →
Ethypharm
HQ: France
Website
- Description: Provider of pharmaceutical products for the treatment of pains and addictions, designing, formulating, developing, manufacturing, and marketing them.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ethypharm company profile →
Newport Labs
HQ: United States
Website
- Description: Provider of veterinary healthcare services and high-quality autogenous biologics for the livestock industry, applying 21st technology to a traditional autogenous approach to formulate products that pinpoint specific disease problems, supported by dedicated employees and innovative solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Newport Labs company profile →
Advanced Analytical Technologies
HQ: United States
Website
- Description: Provider of high-throughput, fully-automated nucleic acid and genetic analysis systems for commercial and research applications, designed to improve processes in the molecular diagnostics, pharmaceutical, life science, agricultural, and biofuels industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Advanced Analytical Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for FEI
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to FEI
2.2 - Growth funds investing in similar companies to FEI
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for FEI
4.2 - Public trading comparable groups for FEI
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →